Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Eric Francisco Contreras-López, Carlos David Cruz-Hernández, Sergio Alberto Cortés-Ramírez, Abril Ramírez-Higuera, Carolina Peña-Montes, Mauricio Rodríguez-Dorantes & Rosa María Oliart-Ros. (2022) Inhibition of Stearoyl-CoA Desaturase by Sterculic Oil Reduces Proliferation and Induces Apoptosis in Prostate Cancer Cell Lines. Nutrition and Cancer 74:4, pages 1308-1321.
Read now
Read now
Articles from other publishers (12)
Xue-Feng Li, Cigdem Selli, Han-Lin Zhou, Jian Cao, Shuiqing Wu, Ruo-Yu Ma, Ye Lu, Cheng-Bin Zhang, Bijie Xun, Alyson D. Lam, Xiao-Cong Pang, Anu Fernando, Zeda Zhang, Asier Unciti-Broceta, Neil O. Carragher, Prakash Ramachandran, Neil C. Henderson, Ling-Ling Sun, Hai-Yan Hu, Gui-Bo Li, Charles Sawyers & Bin-Zhi Qian. (2023) Macrophages promote anti-androgen resistance in prostate cancer bone disease. Journal of Experimental Medicine 220:4.
Crossref
Crossref
Anna E. Harris, Veronika M. Metzler, Jennifer Lothion-Roy, Dhruvika Varun, Corinne L. Woodcock, Daisy B. Haigh, Chantelle Endeley, Maria Haque, Michael S. Toss, Mansour Alsaleem, Jenny L. Persson, Lorraine J. Gudas, Emad Rakha, Brian D. Robinson, Francesca Khani, Laura M. Martin, Jenna E. Moyer, Juliette Brownlie, Srinivasan Madhusudan, Cinzia Allegrucci, Victoria H. James, Catrin S. Rutland, Rupert G. Fray, Atara Ntekim, Simone de Brot, Nigel P. Mongan & Jennie N. Jeyapalan. (2022) Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer. Frontiers in Endocrinology 13.
Crossref
Crossref
Xupeng Wu, Haisong Han, Chao Zhang & Wei Song. (2022) The Overall Survival and Safety of Men with Metastatic Hormone-Sensitive Prostate Cancer Treated with Combination Therapy of Novel Androgen Receptor Antagonists and Androgen-Deprivation Therapy: A Systematic Review and Meta-Analysis. Journal of Oncology 2022, pages 1-14.
Crossref
Crossref
Yash B. Shah, Amy L. Shaver, Jacob Beiriger, Sagar Mehta, Nikita Nikita, William Kevin Kelly, Stephen J. Freedland & Grace Lu-Yao. (2022) Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review. Cancers 14:15, pages 3773.
Crossref
Crossref
Pedro C. Lara, Juan I. Rodríguez-Melcón, Amalia Palacios-Eito, Antonio Lozano, Asunción Hervás-Morón, Elena Villafranca, Alfonso Gómez-Iturriaga, Gemma Sancho & Xavier Maldonado. (2022) Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Tianyan Wang, Martuza Sarwar, Jonathan B Whitchurch, Hilary M Collins, Tami Green, Julius Semenas, Amjad Ali, Christopher J Roberts, Ryan D Morris, Madlen Hubert, Sa Chen, Zahra El-Schich, Anette G Wingren, Thomas Grundström, Richard Lundmark, Nigel P Mongan, Lena Gunhaga, David M Heery & Jenny L Persson. (2022) PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Timothy C. Wright, Victoria L. Dunne, Ali H. D. Alshehri, Kelly M. Redmond, Aidan J. Cole & Kevin M. Prise. (2021) Abiraterone In Vitro Is Superior to Enzalutamide in Response to Ionizing Radiation. Frontiers in Oncology 11.
Crossref
Crossref
Fernanda Majolo, Bruna Caye, Stefani Natali Stoll, Juliano Leipelt, Ana Lúcia Abujamra & Márcia Inês Goettert. (2020) Prevention and Therapy of Prostate Cancer: An Update on Alternatives for Treatment and Future Perspectives. Current Drug Therapy 15:3, pages 168-180.
Crossref
Crossref
Yangguang Liu, Meng Wu, Tianqi Wang, Yongli Xie, Xiangling Cui, Liujun He, Yang He, Xiaoyu Li, Mingliang Liu, Laixing Hu, Shan Cen & Jinming Zhou. (2018) Structural Based Screening of Antiandrogen Targeting Activation Function-2 Binding Site. Frontiers in Pharmacology 9.
Crossref
Crossref
Justyna Szczurek, Marzena Rams-Baron, Justyna Knapik-Kowalczuk, Agata Antosik, Joanna Szafraniec, Witold Jamróz, Mateusz Dulski, Renata Jachowicz & Marian Paluch. (2017) Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures. Molecular Pharmaceutics 14:4, pages 1071-1081.
Crossref
Crossref
Mojie Duan, Na Liu, Wenfang Zhou, Dan Li, Minghui Yang & Tingjun Hou. (2016) Structural Diversity of Ligand-Binding Androgen Receptors Revealed by Microsecond Long Molecular Dynamics Simulations and Enhanced Sampling. Journal of Chemical Theory and Computation 12:9, pages 4611-4619.
Crossref
Crossref
Xiaohong Tian, Yang He & Jinming Zhou. (2015) Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance. Frontiers in Pharmacology 6.
Crossref
Crossref